Loxo-305, A Next Generation, Highly Selective, Non-Covalent Btk Inhibitor In Previously Treated Mantle Cell Lymphoma, Waldenstrom'S Macroglobulinemia, And Other Non-Hodgkin Lymphomas: Results From The Phase 1/2 Bruin Study

BLOOD(2020)

引用 6|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要